Each NeuroPI module is prepared by distinguished faculty who are acknowledged leaders in their respective fields. Each module is composed of a set of multiple-choice items with preferred responses, instructions on how to collect cases to assess one’s practice, and educational resources related to the measure(s) that can be used for design and implementation of an improvement plan. Participants are able to evaluate their performance comparing current practice with measures and best practices to their post-improvement plan results to assess whether goals have been achieved and that changes have occurred in their practice.
Members: FREE $199.00*
*Free access is limited to one course at a time for eligible members.
Through this program, the learner will be able to:
- Identify the different stages of dementia.
- Explain the need to perform a cognitive assessment in patients with dementia.
- Explain the need to perform a functional status assessment in patients with dementia.
- Explain the need to perform a neuropsychiatric assessment in patients with dementia.
- Summarize a management approach for neuropsychiatric symptoms in patients with dementia.
- Perform ongoing screening for depression in patients with dementia.
- Counsel patients diagnosed with dementia regarding safety concerns.
- Counsel patients diagnosed with dementia regarding the risks of driving.
- Counsel patients diagnosed with dementia on palliative care and advanced care planning.
- Discuss education and support with caregivers of patients with dementia.
- Staging of Dementia.
- Cognitive Assessment.
- Functional Status Assessment.
- Neuropsychiatric Symptom Assessment.
- Management of Neuropsychiatric Symptoms.
- Screening for Depressive Symptoms.
- Counseling Regarding Safety Concerns.
- Counseling Regarding Risks of Driving.
- Palliative Care Counseling and Advanced Care Planning.
- Caregiver Education and Support.
As a result of this program, the participant will determine individual practice gaps and address them through a performance improvement plan designed to improve competence, performance, and patient outcomes.
- Interpersonal Skills and Communication
- Medical Knowledge
- Patient Care
- Practice-based Learning and Improvement
Date of Release
November 10, 2015
This module is eligible for CME credits for three years from the release date.
NeuroPI Data Terms & Conditions
The American Academy of Neurology Institute (AANI) no longer requires You (NeuroPI and aan.com user) to provide full date of service (day/month/year); only year of service will be transmitted to and stored by AANI. All previously collected "day" and "month" from date of service records have been deleted from the AANI's NeuroPI database. Accordingly, for NeuroPI, AANI is not requesting or storing any "protected health information" or "limited data sets" as defined by the regulations issued under the Health Insurance Portability and Accountability Act of 1996. The patient data You submit to the AANI through NeuroPI is de-identified health information. You must track patients separately from NeuroPI. Within the NeuroPI modules, Your patients will be identified using a 4-digit patient code that You create. Any other identifying information is strictly prohibited. Please use the NeuroPI Patient Tracker to create Your 4-digit patient codes for Your personal reference. The NeuroPI Patient Tracker must not be shared with AANI.
The American Academy of Neurology Institute either owns or has permission to use all of the NeuroPI module content. You may use these modules for your personal, noncommercial use, but please send permissions requests for any other uses to NeuroPI@aan.com. All of the individual de-identified health information you submit to the AANI through NeuroPI is confidential. Your maintenance of certification ("MOC") credit information is transmitted to the American Board of Psychiatry and Neurology (ABPN) once You've completed a module. You can opt-out of this service in NeuroTracker. Please note, AANI is not a certifying board and members are encouraged to contact ABPN for the most up-to-date information on MOC requirements. You acknowledge that AANI is and shall be deemed the owner of all rights to the aggregate, de-identified data submitted to NeuroPI and subsets of the aggregate data, any and all reports based on the aggregate, de-identified data, and all trademarks and trade secrets arising from or reflected in NeuroPI (collectively, "Aggregate Data"), with the exception of your individual data. AANI has full and unencumbered rights to publish, disclose, distribute, market, sell, and create derivatives of, Aggregate Data in any form.
DAVID KNOPMAN, MD, FAAN
Professor of Neurology
Mayo Clinic, Rochester, MN
*Dr. Knopman has received personal compensation for activities with Lundbeck Pharmaceuticals as a data safety monitoring board member. Dr. Knopman has received personal compensation in an editorial capacity for Neurology. Dr. Knopman has also received research grant support from TauRX Pharmaceuticals and Lilly Pharmaceuticals.
GREGORY JICHA, MD
Associate Professor of Neurology
University of Kentucky College of Medicine, Lexington, KY
*Dr. Jicha has received personal compensation for activities with Lilly Pharmaceuticals as a scientific advisory board member. Dr. Jicha has received contract research support from Lilly and Eszi.
BRIAN OTT, MD, FAAN
Professor of Neurology Alpert Medical School of Brown University, Providence, RI
*Dr. Ott has received personal compensation for activities with Accera as a data safety monitoring board member and Amgen as consultant. Dr. Ott has also received research grant support from Accera, Medscape, NHTSA, Amgen, Merck, TauRx, Biogen, LongTerm Group Care
DONALD J. IVERSON, MD, FAAN
Humboldt Neurological Medical Group, Eureka, California
*Dr. Iverson has nothing to disclose.
Program Manager, Online Learning
*Ms. Chamberlain has nothing to disclose.
+ Unlabeled Use of Products/Investigational Use Disclosure